Hong Kong Consumer Services Stock News

Central New Energy Holding Group (SEHK:1735) reported full year 2025 results, with sales of HK$11,016.85 million, net income of HK$34.24 million, and earnings per share of HK$0.0081 from continuing operations. See our latest analysis for Central New Energy Holding Group. The earnings release comes after a steady run in the shares, with a 9.55% 1 month share price return and 12.30% 3 month share price return. However, the 1 year total shareholder return is still down 6.58% while the 5 year...

Genscript Biotech (SEHK:1548) is back in focus after announcing a multi year collaboration with Mimulus Corp to industrialize DNA based data storage, targeting scalable infrastructure and substantial cost efficiencies by 2030. See our latest analysis for Genscript Biotech. The collaboration headlines come as Genscript Biotech's share price, now at HK$12.62, shows mixed momentum, with a 13.8% 1 month share price return but a 12.42% decline over 3 months. The 1 year total shareholder return...

Zhejiang Expressway Co., Ltd. recently reported its full-year 2025 results, with sales rising to CNY 19.76 billion while net income eased slightly to CNY 5.32 billion, and recommended a higher dividend of CNY 0.395 per share, all subject to approval at the 2025 annual shareholders’ meeting. The combination of revenue growth, a modest earnings dip and a proposed dividend increase highlights management’s emphasis on returning cash to shareholders while operating profitability remains under...

Akeso (SEHK:9926) has come into focus after presenting new lung cancer data at the 2026 European Lung Cancer Congress. The company updated investors on cadonilimab and ivonescimab across difficult non small cell lung cancer settings. See our latest analysis for Akeso. Following the ELCC updates, Akeso's HK$137.8 share price sits on the back of a 25.05% 1 month share price return and 21.62% year to date share price return. The 1 year total shareholder return of 58.48% and 3 year total...

Why the latest results matter for Sinotrans shareholders Sinotrans (SEHK:598) has just reported full year 2025 earnings, with revenue lower than the previous year but higher net income and earnings per share, alongside a proposed final ordinary dividend of RMB 0.155 per share. See our latest analysis for Sinotrans. The latest figures and proposed dividend come after a relatively steady share price, with Sinotrans at HK$4.99 and modest short term moves but very strong 1 year and multi year...

Earnings and dividend proposals in focus Shanghai Industrial Holdings (SEHK:363) recently reported full year 2025 results, with both revenue and net income below the prior year, while at the same time proposing a mix of ordinary and special dividends. See our latest analysis for Shanghai Industrial Holdings. Since the annual results and dividend proposals were released, the share price has edged up, with a 1-day share price return of 0.99% and a 7-day share price return of 2.16%. The 1-year...

Earnings trigger: narrowing losses at GR Life Style GR Life Style (SEHK:108) has drawn attention after reporting full year 2025 results, with net loss at HK$109.63 million versus HK$918.5 million a year earlier, and basic loss per share at HK$0.0341. See our latest analysis for GR Life Style. The earnings update comes after a mixed run for the stock, with the latest share price at HK$2.8, a 1-day share price return of 4.09%, a 90-day share price return decline of 9.39%, a very large 1-year...

China Overseas Land & Investment (SEHK:688) caught investor attention after reporting March contracted property sales of about RMB28.578b, up 34.8% year on year, with first quarter contracted sales up 11% to roughly RMB51.52b. See our latest analysis for China Overseas Land & Investment. Even with the strong first quarter contracted sales update, the recent 30 day share price return decline of 6.8% and year to date share price return decline of 4.48% sit alongside a 1 year total shareholder...

Innovent Biologics (SEHK:1801) shares moved in response to fresh product news after the company presented initial preclinical data for IBI3055, a tri specific anti CD19/BCMA/CD3 T cell engager for autoimmune diseases, in Boston. See our latest analysis for Innovent Biologics. The latest IBI3055 update lands after a mixed but generally positive stretch for investors, with a 30 day share price return of 9.46%, year to date share price return of 12.31%, and a 1 year total shareholder return of...

Why WH Group’s latest share price high matters WH Group (SEHK:288) has reached an all time share price high after an upstream turnaround linked to the US hog market upcycle, higher dividends, and a larger role for more stable downstream operations. See our latest analysis for WH Group. At a share price of HK$10.83, WH Group has built solid momentum, with a 30 day share price return of 14.0% and a 1 year total shareholder return of 82.01%, reflecting stronger sentiment around earnings...

Earlier this month, JP Morgan issued a research report naming China Telecom as one of its preferred defensive yield plays among Chinese equities, assigning the stock an Overweight rating and emphasizing its income profile in the current macro backdrop. The report’s focus on China Telecom’s resilience and dividend appeal highlights how major institutions may be viewing the company as a potential anchor for investors seeking relative stability within China’s equity market. We’ll now look at...

CSSC Offshore & Marine Engineering (Group) (SEHK:317) has drawn fresh attention after issuing 2026 earnings guidance targeting operating income of CN¥21.218b, along with a proposed cash dividend that would distribute roughly 30.14% of annual net profit. See our latest analysis for CSSC Offshore & Marine Engineering (Group). The 7 day share price return of 7.77% at a latest share price of HK$13.87 contrasts with a 30 day share price return decline of 11.66%. However, the 1 year total...

ICBC’s new Tier 2 notes and shareholder meeting: why they matter now Industrial and Commercial Bank of China (SEHK:1398) has just completed a CNY 50b Tier 2 capital note issuance at a fixed 2% coupon and called an extraordinary shareholders’ meeting focused on audited accounts, dividends, and 2026 investment plans. See our latest analysis for Industrial and Commercial Bank of China. ICBC’s recent Tier 2 issuance and upcoming shareholder meeting come after a period where the 1 month share...

Chery Automobile stock moves after recent performance shift Chery Automobile (SEHK:9973) has caught investor attention after a recent shift in its share performance, with the stock’s past month return of 22.72% standing out compared with its movement over the past three months. See our latest analysis for Chery Automobile. The recent 22.72% 1 month share price return contrasts with a more modest 6.95% share price return year to date. This suggests momentum has picked up lately as investors...

Horizon Robotics (SEHK:9660) recently began executing a shareholder‑approved buyback program that allows repurchases of up to 1.32 billion shares, or 10% of its issued share capital, funded from legally available resources under its governing rules and laws. The company expects these repurchases to lift net asset value per share and earnings per share, sharpening investor focus on its capital allocation alongside its expanding automotive AI chip portfolio. Next, we’ll examine how Horizon...

Why 3SBio’s latest earnings and dividend decision matter 3SBio (SEHK:1530) has drawn fresh attention after reporting full year 2025 results alongside a reaffirmed final dividend. This combination puts both profitability and cash returns to shareholders in focus. The company reported sales of CNY 17,695.75 million and net income of CNY 8,482.16 million for 2025, with basic earnings per share from continuing operations at CNY 3.51 and diluted earnings per share at CNY 3.43. See our latest...

March 2026 production and sales snapshot Great Wall Motor (SEHK:2333) has drawn fresh attention after reporting unaudited March 2026 production of 122,881 units and sales of 106,198 units, with both figures above the levels reported a year earlier. For the year to date, unaudited production reached 277,766 units and sales came in at 269,104 units, each above the comparable period in the prior year, giving investors new data points ahead of the upcoming first quarter board review. See our...

361 Degrees International (SEHK:1361) has called its 2026 Annual General Meeting for 15 May, putting a 10% share buy-back mandate, final dividend, and key governance decisions in front of shareholders. See our latest analysis for 361 Degrees International. The AGM news lands after a strong run in the share price, with a 30 day share price return of 28.84% and a 1 year total shareholder return of 71.19%, suggesting momentum has been building recently. If this AGM has you thinking about where...

Why China Ruyi’s Earnings Turnaround Matters China Ruyi Holdings (SEHK:136) reported a full year earnings turnaround for 2025, shifting from a net loss to a net profit of CN¥1,796.64 million, which is drawing fresh attention to the stock. Sales for the year came in at CN¥3,342.98 million. Basic and diluted earnings per share from continuing operations were CN¥11.42, compared with a basic and diluted loss per share of CN¥1.57 a year earlier. See our latest analysis for China Ruyi Holdings. The...

Link Real Estate Investment Trust (SEHK:823) has agreed to sell its 56% stake in Singapore retail property Swing By@Thomson Plaza for SGD250 million, at a premium to both its book value and its acquisition price. See our latest analysis for Link Real Estate Investment Trust. The Swing By@Thomson Plaza sale comes after a period of stronger price momentum, with a 7 day share price return of 5.18% and a 90 day share price return of 11.44%. The 1 year total shareholder return of 24.00% contrasts...

BYD (SEHK:1211) is in focus after a series of user experience moves, from rapid nine minute drive thru charging at KFC sites in China to new Cerence powered in car AI assistants. See our latest analysis for BYD. The recent partnerships with Yum China and Cerence come as momentum in BYD’s share price has been picking up, with a 30 day share price return of 7.03% and a 90 day share price return of 11.16%. Over a 1 year period the total shareholder return is negative, while the 3 and 5 year...

Celebrations may be in order for Shanghai MicroPort MedBot (Group) Co., Ltd. ( HKG:2252 ) shareholders, with the...

Earnings and dividend update Zhejiang Expressway (SEHK:576) has drawn fresh attention after releasing its full year 2025 results, showing higher sales, softer net income, and a slightly higher recommended dividend, all pending shareholder approval. See our latest analysis for Zhejiang Expressway. The latest earnings, dividend proposal and news of a board change have come alongside a 9.1% 30 day share price return and a 26.8% 1 year total shareholder return. This combination may suggest...

Sugemalimab’s new Category I, A recommendation in European Society for Medical Oncology guidance for early and locally advanced non small cell lung cancer puts CStone Pharmaceuticals (SEHK:2616) firmly in focus for investors tracking oncology developments. See our latest analysis for CStone Pharmaceuticals. The ESMO endorsement arrives alongside strong recent trading, with the HK$10.07 share price supported by a 30 day share price return of 38.32% and a 1 year total shareholder return above...